Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies

References

Page 1

	Year	Citations
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Catherine Uyttenhove, Luc Pilotte, Ivan Théate, Nature Medicine InflammationCancer ImmunosurveillanceBiochemistryImmunologyTumor Immunity	2003	2.3K
Conditioning Diagnostics: Collinearity and Weak Data in Regression Richard Goldstein, David A. Belsley Technometrics Diagnostic CriterionDiagnosisRegression AnalysisWeak DataStatistics	1993	898
Conditioning Diagnostics: Collinearity and Weak Data in Regression. L. I. Pettit, D. A. Belsley Journal of the Royal Statistical Society Series C (Applied Statistics) Isbn 0MedicineDiagnostic CriterionDiagnosisBiostatistics	1992	579
Indoleamine 2,3-dioxygenase. Purification and some properties Takeshi Shimizu, Shuji Nomiyama, Fusao Hirata, Journal of Biological Chemistry Protoheme IxAldehyde DehydrogenaseBiochemistryIndoleamine 2,3-DioxygenaseNatural Sciences	1978	365
Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. R. Kubota, Kazuo Kubota, Satoru Yamada, PubMed	1994	264
Novel Prognostic Immunohistochemical Biomarker Panel for Estrogen Receptor–Positive Breast Cancer Brian Z. Ring, Robert S. Seitz, Rod Beck, Journal of Clinical Oncology	2006	180
<scp>l</scp>‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms Kyoichi Kaira, Noboru Oriuchi, Hisao Imai, Cancer Science	2008	158
Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival Vaibhav P. Pai, Aaron M. Marshall, Laura L. Hernandez, Breast Cancer Research	2009	155
Discovery and Characterization of Novel Tryptophan Hydroxylase Inhibitors That Selectively Inhibit Serotonin Synthesis in the Gastrointestinal Tract Qingyun Liu, Qi Yang, Weimei Sun, Journal of Pharmacology and Experimental Therapeutics	2008	153
Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Hisao Imai, Kyoichi Kaira, Noboru Oriuchi, PubMed	2010	129

Page 1